This is the
talk page for discussing improvements to the
Medical uses of bicalutamide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Medical uses of bicalutamide.
|
![]() | Text and/or other creative content from this version of Bicalutamide was copied or moved into Medical uses of bicalutamide with this edit on 00:14, 20 November 2017. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
I check pages listed in Category:Pages with incorrect ref formatting to try to fix reference errors. One of the things I do is look for content for orphaned references in wikilinked articles. I have found content for some of Medical uses of bicalutamide's orphans, the problem is that I found more than one version. I can't determine which (if any) is correct for this article, so I am asking for a sentient editor to look it over and copy the correct ref content into this article.
Reference named "JamesonGroot2015":
Reference named "WilliamsBigby2009":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Chang2005":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "AHFS2016":
{{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Smith2013":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Shapiro2012":
Reference named "IversenMelezinek2001":
Reference named "pmid12353966":
An estimated 0.77% of the 6,480 nilutamide-treated patients, 0.04% of the 41,700 flutamide-treated patients, and 0.01% of the 86,800 bicalutamide-treated patients developed pneumonitis during the study period.
An estimated 0.77% of the 6,480 nilutamide-treated patients, 0.04% of the 41,700 flutamide-treated patients, and 0.01% of the 86,800 bicalutamide-treated patients developed pneumonitis during the study period.
Reference named "WeinKavoussi2011":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "SinghGauthier2000":
When compared to flutamide, [cyproterone acetate] has significant intrinsic androgenic and estrogenic activities. [...] The effects of flutamide and the steroidal derivatives, cyproterone acetate, chlormadinone acetate, megestrol acetate and medroxyprogesterone acetate were compared in vivo in female nude mice bearing androgen-sensitive Shionogi tumors. All steroidal compounds stimulated tumor growth while flutamide had no stimulatory effect [51]. Thus, CPA due to its intrinsic properties stimulates androgen-sensitive parameters and cancer growth. Cyproterone acetate added to castration has never been shown in any controlled study to prolong disease-free survival or overall survival in prostate cancer when compared with castration alone [152-155].
Reference named "Regitz-Zagrosek2012":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Lehne2013":
Reference named "Dart2004":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "MydloGodec2015":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Gooren2011":
Reference named "Kaplowitz2002":
Reference named "DenisGriffiths1999":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)I apologize if any of the above are effectively identical; I am just a simple computer program, so I can't determine whether minor differences are significant or not. AnomieBOT ⚡ 03:32, 20 November 2017 (UTC)
This is the
talk page for discussing improvements to the
Medical uses of bicalutamide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Medical uses of bicalutamide.
|
![]() | Text and/or other creative content from this version of Bicalutamide was copied or moved into Medical uses of bicalutamide with this edit on 00:14, 20 November 2017. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
I check pages listed in Category:Pages with incorrect ref formatting to try to fix reference errors. One of the things I do is look for content for orphaned references in wikilinked articles. I have found content for some of Medical uses of bicalutamide's orphans, the problem is that I found more than one version. I can't determine which (if any) is correct for this article, so I am asking for a sentient editor to look it over and copy the correct ref content into this article.
Reference named "JamesonGroot2015":
Reference named "WilliamsBigby2009":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Chang2005":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "AHFS2016":
{{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite web}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Smith2013":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help){{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Shapiro2012":
Reference named "IversenMelezinek2001":
Reference named "pmid12353966":
An estimated 0.77% of the 6,480 nilutamide-treated patients, 0.04% of the 41,700 flutamide-treated patients, and 0.01% of the 86,800 bicalutamide-treated patients developed pneumonitis during the study period.
An estimated 0.77% of the 6,480 nilutamide-treated patients, 0.04% of the 41,700 flutamide-treated patients, and 0.01% of the 86,800 bicalutamide-treated patients developed pneumonitis during the study period.
Reference named "WeinKavoussi2011":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "SinghGauthier2000":
When compared to flutamide, [cyproterone acetate] has significant intrinsic androgenic and estrogenic activities. [...] The effects of flutamide and the steroidal derivatives, cyproterone acetate, chlormadinone acetate, megestrol acetate and medroxyprogesterone acetate were compared in vivo in female nude mice bearing androgen-sensitive Shionogi tumors. All steroidal compounds stimulated tumor growth while flutamide had no stimulatory effect [51]. Thus, CPA due to its intrinsic properties stimulates androgen-sensitive parameters and cancer growth. Cyproterone acetate added to castration has never been shown in any controlled study to prolong disease-free survival or overall survival in prostate cancer when compared with castration alone [152-155].
Reference named "Regitz-Zagrosek2012":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Lehne2013":
Reference named "Dart2004":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "MydloGodec2015":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)Reference named "Gooren2011":
Reference named "Kaplowitz2002":
Reference named "DenisGriffiths1999":
{{
cite book}}
: Unknown parameter |deadurl=
ignored (|url-status=
suggested) (
help)I apologize if any of the above are effectively identical; I am just a simple computer program, so I can't determine whether minor differences are significant or not. AnomieBOT ⚡ 03:32, 20 November 2017 (UTC)